AndreaBozzo/ceres-open-data-index huggingface dataset:
Indicators for 2012A

Physician Fee Schedule - March 2012 release. This file contains the revisions identified in the Middle Class Tax Relief and Job Creation Act of 2012 (MCTRJCA). Medicare payment rates under the Medicare Physician Fee Schedule (MPFS) are set according to statutory criteria. The following 2012 MPFS payment rates are reflective of the CY 2012 Medicare Physician Fee Schedule Final Rule, which was published in the Federal Register on November 28, 2011, and the CY 2012 Medicare Physician Fee Schedule Final Rule Correction Notice, which was published in the Federal Register on January 4, 2012. These payment rates are based on current law, including the Middle Class Tax Relief and Job Creation Act of 2012 (MCTRJCA), which provides for a zero percent update through December 31, 2012. The MCTRJCA extends several provisions of the Temporary Payroll Tax Cut Continuation Act of 2011 (TPTCCA). Please note that MCTRJCA does NOT extend add-on payments for mental health services and minimum payment for bone mass measurement (sections 307 and 309 of the TPTCCA, respectively). As such, effective March 1, 2012, the MPFS payment rates for these services have changed. 2012A: Medicare payment rates under the Medicare Physician Fee Schedule (MPFS) are set according to statutory criteria. The following 2012 MPFS payment rates are reflective of the CY 2012 Medicare Physician Fee Schedule Final Rule, which was published in the Federal Register on November 28, 2011, and the CY 2012 Medicare Physician Fee Schedule Final Rule Correction Notice that was put on display at the Office of the Federal Register on December 30, 2011. These payment rates are based on current law, including the Temporary Payroll Tax Cut Continuation Act of 2011, which provides for a zero percent update for the period of January 1, 2012 to February 29, 2012. The Centers for Medicare and Medicaid Services will work quickly to update MPFS payment rates in the event Congress passes legislation to prevent the negative update from going into effect on March 1, 2012. Please be on the alert for more information about the 2012 physician update as it becomes available.
List of AFCARS Out-of-Home Care and Adoption and Guardianship Assistance Elements with response options

This is a list of the Out-of-Home Care and Adoption and Guardianship Assistance data elements with response options and regulatory citations as published in the AFCARS final rule issued on December 14, 2016 (81 FR 90524
  
  

)

Metadata-only record linking to the original dataset. Open original dataset below.
Reporting of measures of accuracy in systematic reviews of diagnostic literature

Background
          There are a variety of ways in which accuracy of clinical tests can be summarised in systematic reviews. Variation in reporting of summary measures has only been assessed in a small survey restricted to meta-analyses of screening studies found in a single database. Therefore, we performed this study to assess the measures of accuracy used for reporting results of primary studies as well as their meta-analysis in systematic reviews of test accuracy studies.
        
        
          Methods
          Relevant reviews on test accuracy were selected from the Database of Abstracts of Reviews of Effectiveness (1994–2000), which electronically searches seven bibliographic databases and manually searches key resources. The structured abstracts of these reviews were screened and information on accuracy measures was extracted from the full texts of 90 relevant reviews, 60 of which used meta-analysis.
        
        
          Results
          Sensitivity or specificity was used for reporting the results of primary studies in 65/90 (72%) reviews, predictive values in 26/90 (28%), and likelihood ratios in 20/90 (22%). For meta-analysis, pooled sensitivity or specificity was used in 35/60 (58%) reviews, pooled predictive values in 11/60 (18%), pooled likelihood ratios in 13/60 (22%), and pooled diagnostic odds ratio in 5/60 (8%). Summary ROC was used in 44/60 (73%) of the meta-analyses. There were no significant differences in measures of test accuracy among reviews published earlier (1994–97) and those published later (1998–2000).
        
        
          Conclusions
          There is considerable variation in ways of reporting and summarising results of test accuracy studies in systematic reviews. There is a need for consensus about the best ways of reporting results of test accuracy studies in reviews.
Patent AT-E400999-T1: [Translated] SYSTEM FOR MARKING A BIOLOGICAL OBJECT AND FOR SAMPLING FROM THE BIOLOGICAL OBJECT

A system for marking a biological object and taking a sample of the biological object, which object is in particular an animal. The system comprises a first tag part ( 1 ), a second tag part ( 2 ) and a pin ( 3 ), having a first end and a second end, which pin is connected to the first tag part by its first end and which pin is provided with a head ( 4 ) at its second end. The second tag part is provided with a receiving opening ( 5 ) for the head of the pin, such that the pin can be pressed through a part of the biological object, in particular through the ear of an animal, and subsequently through the receiving opening of the second tag part, as a result of which the first and second tag parts are attached to one another and to the biological object via the pin. The system furthermore comprises a sample container with an opening for introducing a sample of biological material of the object into the sample system for marking a biological object and taking a sample of the biological object, which object is in particular an animal. The system comprises a first tag part, a second tag part pin, having a first end and a second end, which pin is connected to the first tag part by its first end and which pin is provided with a head at its second end. The second tag part is provided with a receiving opening for the head of the pin, such that the pin can be pressed through a part of the biological object, in particular through the ear of an animal, and subsequently through the receiving opening of the second tag part, as a result of which the first and second tag parts are attached to one another and to the biological object via the pin. The system furthermore comprises a sample container with an opening for introducing a sample of biological material of the object into the sample container, which sample container has a body with a peripheral wall and an opening at an axial end and a bottom at the opposite axial end. The sample container ( 10 ) is attached to the second tag part via a releasable connection, in such a manner that the opening of the sample container and the receiving opening of the second tag part lie in line. The system furthermore comprises a stopper ( 20 ) for sealing the opening after the sample has been introduced into the sample container, which stopper is on the head of the pin. While the pin is being pushed through the biological object, a sample of the biological object is taken and introduced into the sample container, following which the opening of the sample container is sealed by the stopper. The stopper is at least partially transparent, such that the introduction of a sample into the sample container can be checked visually.
Compound 526299: 1,4-Dibromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,4-dibromodibenzofuran. Molecular Formula: C12H6Br2O. Molecular Weight: 325.98. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Effects of E-Cigarette Flavoring Chemicals on Human Macrophages and Bronchial Epithelial Cells

E-cigarettes utilize a wide range of flavoring chemicals whose respiratory health effects are not well understood. In this study, we used pulmonary-associated cell lines to assess the in vitro cytotoxic effects of thirty flavoring chemicals. Human bronchial epithelial cells (BEAS-2B) and both naïve and activated macrophages (THP-1) were treated with 10, 100, and 1000 µM of flavoring chemicals and analyzed for changes in viability, cell membrane damage, reactive oxygen species (ROS) production, and inflammatory cytokine release. Viability was most greatly affected by decanal, hexanal, nonanal, cinnamaldehyde, eugenol, vanillin, alpha-pinene, eugenol, and limonene. High amounts of ROS were elicited by vanillin, ethyl maltol, and the diketones (2,3-pentanedione, 2,3-heptanedione, and 2,3-hexanedione) from both cell lines. Naïve THP-1 cells produced significant levels of IL-1β, IL-8, and TNF-α when exposed to ethyl maltol and hexanal. Activated THP-1 cells released increased IL-1β and TNF-α when exposed to ethyl maltol, but many flavoring chemicals had an apparent suppressive effect on inflammatory cytokines released by activated macrophages, with varying degrees of accompanying cytotoxicity. The diketones, L-carvone, and linalool, suppressed cytokine release in the absence of cytotoxicity. These findings provide insight into patterns of cytotoxicity and inflammatory cytokine release potentially relevant to the development of pathological changes in the lungs of e-cigarette users.
Compound 530413: Silanol, trimethyl-, carbonate (2:1)

Chemical compound data from PubChem database. IUPAC Name: bis(trimethylsilyl) carbonate. Molecular Formula: C7H18O3Si2. Molecular Weight: 206.39. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Motor Vehicle Occupant Death Rate, by Age and Sex, 2012 & 2014, Region 7 - Kansas City

Rate of deaths by age/gender (per 100,000 population) for motor vehicle occupants killed in crashes, 2012 & 2014. 2012 Source: Fatality Analysis Reporting System (FARS). 2014 Source: National Highway Traffic Safety Administration's (NHTSA) Fatality Analysis Reporting System (FARS), 2014 Annual Report File Note: Blank cells indicate data are suppressed. Fatality rates based on fewer than 20 deaths are suppressed.
Treatment Episode Data Set (TEDS): 1992-1996, National Admissions to Substance Abuse Treatment Services

This report presents data from the Treatment Episode Data Set (TEDS) for 1996, and trend data for 1992 to 1996. The report provides information on the demographic and substance abuse characteristics of people aged 12 and older admitted to treatment for abuse of alcohol and/or drugs in facilities that report to individual state administrative data systems.
Patent AT-E401790-T1: [Translated] PHEROMONES AND METHOD FOR PREVENTING CONTARINIA NASTURTII INFESTATION

The present invention relates to pheromone mixture comprising 2,9 diacetoxyundecane, 2,10-diacetoxyundecane and 2-acetoxyundecane, as a racemate or, biologically active stereoisomers thereof, as well as a method for monitoring and/or mating disruption of swede midge, Contarinia nasturtii, in Brassica vegetables, in particular Brussels sprouts, cauliflower and broccoli.
Compound 526425: 3-Ethyl-3,6-dimethyloctane

Chemical compound data from PubChem database. IUPAC Name: 3-ethyl-3,6-dimethyloctane. Molecular Formula: C12H26. Molecular Weight: 170.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Michigan (MI)

This report presents Michigan\'s estimates for 25 measures of substance use and mental health based on the combined 2009 and 2010 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for Michigan for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Compound 527352: 16,20,24-Trimethyl-tritriacontyl cyanide

Chemical compound data from PubChem database. IUPAC Name: 17,21,25-trimethylpentatriacontanenitrile. Molecular Formula: C38H75N. Molecular Weight: 546.0. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401187-T1: [Translated] DEVICE FOR PRODUCING PLASTIC FILMS

A calibrating basket for calibrating the extruded plastic tube has guiding bows(2) carrying guide rolls(4) for the tubular film. The guide rolls are formed by anti friction roller bearings. Each bearing has an inner ring(6) fixed to a guide bow(2) and a rotatable outer ring(7) supported via rollers(8) on the inner ring. An anti-adhesion coating covers the surface(11) of the outer ring. A gap exists between rollers on the guide bow.
Deaths in 122 U.S. cities - 1962-2016. 122 Cities Mortality Reporting System

This file contains the complete set of data reported to 122 Cities Mortality Reposting System.  The system was retired as of 10/6/2016.  While the system was running each week, the vital statistics offices of 122 cities across the United States reported the total number of death certificates processed and the number of those for which pneumonia or influenza was listed as the underlying or contributing cause of death by age group (Under 28 days, 28 days - 1 year, 1-14 years, 15-24 years, 25-44 years, 45-64 years, 65-74 years, 75-84 years, and - 85 years).  U:Unavailable. - : No reported cases.* Mortality data in this table were voluntarily reported from 122 cities in the United States, most of which have populations of >100,000. A death is reported by the place of its occurrence and by the week that the death certificate was filed. Fetal deaths are not included.  Total includes unknown ages. 
More information on Flu Activity & Surveillance is available at http://www.cdc.gov/flu/weekly/fluactivitysurv.htm.
Compound 526693: 2,3-di-O-acetyl-1,4-anhydro-4-O-methyl-D-fucitol

Chemical compound data from PubChem database. IUPAC Name: (4-acetyloxy-5-methoxy-6-methyloxan-3-yl) acetate. Molecular Formula: C11H18O6. Molecular Weight: 246.26. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400415-T1: [Translated] TABLE SAW MACHINE

The table circular saw machine has a guide device (14) fixed from the fixture position on or near to the tool carrier (3) for lateral guide of the gap wedge retainer (11) during height adjustment. On the gap wedge retainer near to the tool carrier is a vertically running adjustment slot (12). Two support screws (13) arranged one above the other hold the gap wedge retainer on the housing (8), so that it can be adjusted in height. Height adjustment can be effected with e.g. a customary hand crank.  The support screws together with the plate of the housing on the saw table and the adjustment slot in the gap wedge retainer therefore form a vertically directed adjustment guide. Laterally spaced from this guide is a second guide device (14), formed so that the gap wedge retainer has an edge-side guide rail (15). The second guide device has at least one guide angle (14',14'') on the saw table, in which the guide rail is laterally moved during height adjustment of the gap wedge retainer.
High frequency oscillatory ventilation attenuates the activation of alveolar macrophages and neutrophils in lung injury

Background:
          Recent investigations have shown that leukocyte activation is involved in the pathogenesis of ventilator-associated lung injury. This study was designed to investigate whether the inflammatory responses and deterioration of oxygenation in ventilator-associated lung injury are attenuated by high-frequency oscillatory ventilation (HFO). We analyzed the effects of HFO compared with conventional mechanical ventilation (CMV) on the activation of pulmonary macrophages and neutrophils in 10 female rabbits.
        
        
          Results:
          After surfactant depletion, the rabbits were ventilated by CMV or HFO at the same mean airway pressure. Surfactant-depletion followed by 4 h mechanical ventilation hindered pulmonary oxygenation in both groups. Impairment of oxygenation was less severe in the HFO group than in the CMV group. In the HFO group the infiltration of granulocytes into alveolar spaces occurred more readily than in the CMV group. Compared with CMV, HFO resulted in greater attenuation of β2-integrin expression, not only on granulocytes, but also on macrophages.
        
        
          Conclusions:
          In the surfactant-depleted lung, the activation of leukocytes was attenuated by HFO. Reduced inflammatory response correlated with decreased impairment of oxygenation. HFO may reduce lung injury via the attenuation of pulmonary inflammation.
Compound 530604: p-Anisic acid, 1-adamantylmethyl ester

Chemical compound data from PubChem database. IUPAC Name: 1-adamantylmethyl 4-methoxybenzoate. Molecular Formula: C19H24O3. Molecular Weight: 300.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400608-T1: [Translated] STABILIZER COMPOSITION FOR FOAM OF HALOGEN-CONTAINING POLYMERS

A stabiliser composition for foams of halogen-containing polymers, comprising from 0.01 to about 50% by weight of at least one salt of a halogen-containing oxyacid and from 0.5 to about 50% by weight of at least one blowing agent, both based on the total weight of the stabiliser composition.
Phase Level Assessment of Ergonomic Intervention Effectiveness in Reducing Knee Musculoskeletal Disorder Risks during Residential Roof Shingle Installation

The prevalence of knee musculoskeletal disorders (MSDs) among roofers due to ergonomically unfavorable kneeling postures during shingle installation is a well-recognized concern. While knee-saving interventions like knee savers (KSs) and knee pads (KPs) have shown potential to reduce MSD risks, their effectiveness across different phases of shingle installation remains unknown. The objective of this study is to assess how interventions of KSs and KPs alleviate risks of MSDs in the knees during various phases of shingle installation. These phases encompass (1) reaching for shingles, (2) placing shingles, (3) grabbing a nail gun, (4) moving to the first nailing position, (5) nailing shingles, (6) replacing the nail gun, and (7) returning to an upright position. To collect data, nine male participants simulated the shingle installation task on a slope-adjustable roof platform (0°, 15°, and 30° slopes) under four intervention conditions: no intervention (NO), with KPs only (KP), with KSs only (KS), and with both KPs and KSs (BO) in a laboratory setting. Knee parameters including maximum flexion, abduction, adduction, and internal/external rotations were measured at all phases to assess intervention impacts through statistical analysis.
Glycosylation and the cystic fibrosis transmembrane conductance regulator

The cystic fibrosis transmembrane conductance regulator (CFTR) has been known for the past 11 years to be a membrane glycoprotein with chloride channel activity. Only recently has the glycosylation of CFTR been examined in detail, by O'Riordan et al in Glycobiology. Using cells that overexpress wild-type (wt)CFTR, the presence of polylactosamine was noted on the fully glycosylated form of CFTR. In the present commentary the results of that work are discussed in relation to the glycosylation phenotype of cystic fibrosis (CF), and the cellular localization and processing of ΔF508 CFTR. The significance of the glycosylation will be known when endogenous CFTR from primary human tissue is examined.
Compound 529748: (2,7,7-Trimethyl-6-bicyclo[3.1.1]hept-2-enyl) butanoate

Chemical compound data from PubChem database. IUPAC Name: (2,7,7-trimethyl-6-bicyclo[3.1.1]hept-2-enyl) butanoate. Molecular Formula: C14H22O2. Molecular Weight: 222.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
AH Provisional COVID-19 Deaths by Age, United States, Week 40 2020 through Week 39 2021

Provisional deaths involving coronavirus disease 2019 (COVID-19) reported to NCHS by age group among United States residents, from MMWR Week 40 2020 through MMWR Week 39 2021.

Age groups: 0-4, 5-11, 12-15, 16-17, 18-24, 25-39, 40-49, 50-64, 65-74, and 75+ years
Patent AT-E399858-T1: [Translated] FLOWER ORGAN-SPECIFIC PROMOTER SEQUENCES

This invention provides a flower organ-specific promoter enabling genetic engineering manipulations of pistil or lodicule. It further provides a novel chitinase expressed specifically in flower organ and its gene. The flower organ-specific promoter of the present invention is contained in the sequence consisting of nucleotides of positions from 1 to 1234 in the nucleotide sequence represented by SEQ ID NO:2 in Sequence Listing. The promoter of the present invention includes sequences derived from the above sequence by deletion, substitution, insertion or addition of one or more nucleotides and having a flower organ-specific promoter activity and also those obtainable by using the nucleotide sequence represented by SEQ ID NO:1 in Sequence Listing as a probe and having a flower organ-specific promoter activity. The flower organ-specific chitinase gene of the present invention is one consisting of the nucleotide sequence of positions from 1 to 1097 in the nucleotide sequence represented by SEQ ID NO:1 in Sequence Listing. Moreover, it involves a part of this sequence and DNA fragments having a sequence derived from said sequences by deletion, substitution, insertion or addition of one or more nucleotides and encoding a protein having a biological activity equivalent to that of the protein encoded by the DNA consisting of the above nucleotide sequence. The flower organ-specific chitinase of the present invention consists of the amino acid sequence represented by SEQ ID NO:3 in Sequence Listing. Moreover, it includes a part of this amino acid sequence or amino acid sequences having a sequence derived from these amino acids by deletion, substitution, insertion or addition of one or more amino acids and constituting a protein having a biological activity equivalent to that of the protein consisting of the above amino acid sequence.
Medicare Dialysis Facilities

The Medicare Dialysis Facilities data provides information on clinical and patient measures for Medicare-certified ESRD facilities, also known as dialysis facilities. It contains data on patient characteristics, treatment patterns, hospitalization, mortality, and transplantation patterns in Medicare-certified dialysis facilities.

 

The following four data files are available for download each year, where yyyy denotes the fiscal year.


	DFR_Data_FYyyyy.csv file includes all summaries (facility- and regional-level) reported in the Dialysis Facility Report (DFR). The file includes one record for each dialysis facility and is the file recommended for download (i.e., wide format).
	dfr_facility_socrata_fyyyyy.csv file includes only facility-level summaries reported in the DFR. The file includes one record per measure per year (i.e., long format) and contains more records than most spreadsheet programs can handle, which will result in an incomplete load of data. Use of a database or statistical software is required.
	dfr_us_state_socrata_fyyyyyy.csv file includes state- and national-level summaries reported in DFR. The file includes one record per measure per year (i.e., long format).
	dfr_network_socrata_fyyyyyy.csv file includes ESRD network-level summaries reported in the DFR. The file includes one record per measure per year (i.e., long format).